SARS News and Research

RSS

BU researchers win NIH grant to examine the impact of COVID-19 vaccines on menstruation

The National Institutes of Health has awarded one-year supplemental grants totaling $1.67 million to five institutions, including Boston University School of Public Health, to explore potential links between COVID-19 vaccination and menstrual changes.

12 Sep 2021

The strengths and weaknesses of the spike protein in SARS-CoV-2 variants

The S protein has the ability to appropriate various conformations that are dependent on the formation of the receptor-binding domain (RBD) of its protomers.

12 Sep 2021

Does Delta increase the risk of hospitalization compared with Alpha?

A team of researchers conducted a cohort study to understand the risk of hospitalization in patients with either the Delta or Alpha variants of SARS-CoV-2.

12 Sep 2021

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Beckman researchers paired microscopy with artificial intelligence to develop a COVID-19 test that's fast, accurate, and cost-effective. All we need to do is say "ahh."

12 Sep 2021

Multilateral system has failed badly during COVID-19 pandemic, says ISC president-elect

The multilateral system has failed badly during the COVID-19 pandemic, according to the incoming head of the International Science Council, a global body that counts the world's science academies as its members.

12 Sep 2021

Drugs that mimic effects of cigarette smoke could become a potential tool to fight COVID-19

Researchers have identified two drugs that mimic the effect of chemicals in cigarette smoke to bind to a receptor in mammalian cells that inhibits production of ACE2 proteins, a process that appears to reduce the ability of the SARS-CoV-2 virus to enter the cell.

12 Sep 2021

UGA research offers hope for a viable therapeutic to combat COVID-19

As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2.

11 Sep 2021

Brown researchers receive $4.9 million to study COVID-19 vaccine effectiveness in older adults

To address the pressing issue of diminishing immunity among older adults to COVID-19 as well to vaccines designed to protect against the virus, a $4.9 million award from the U.S. Centers for Disease Control and Prevention will fund a two-year project led by Brown University researchers and conducted by a team spanning multiple institutions.

10 Sep 2021

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Despite the development of SARS-CoV-2 vaccines, effective therapeutics are needed until worldwide immunity has been achieved.

10 Sep 2021

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

A genomic surveillance analysis of SARS-CoV-2 in Africa in the first year of the pandemic reveals that the first phase of the pandemic there was caused by importations from outside Africa, and involved limited virus spread, while the second, more deadly phase was fueled by ongoing transmission within the continent and led to emergence of many variants of concern.

10 Sep 2021

INCB, UNODC and WHO call on governments to facilitate access to controlled medicines in emergencies

Recognizing World Humanitarian Day 2021, the International Narcotics Control Board, the United Nations Office on Drugs and Crime and the World Health Organization once again call on governments to facilitate access to medicines containing controlled substances in emergency settings, including during pandemics and the increasing number of climate-related disasters.

10 Sep 2021

Nanoparticles-assisted delivery of antiviral-siRNA for treatment of COVID-19

A review aimed to determine the potential of siRNA as a potential COVID-19 treatment by reviewing the currently available literature.

10 Sep 2021

School children in Switzerland show willingness to mask-wearing

A school-based survey has revealed that about 60% of students in Zurich perceive mask-wearing at school as a useful intervention for controlling SARS-CoV-2 transmission.

10 Sep 2021

SARS-CoV-2 transmission dynamics in Nordic countries

Scientists have recently assessed the strategies adopted by the Nordic countries to curb the trajectory of the COVID-19 pandemic.

10 Sep 2021

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

Scientists evaluated the effect of vaccination in breastfeeding women and its possible effects in infants in a study involving 180 fully vaccinated, breastfeeding women.

10 Sep 2021

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

A group of researchers analyzed the B cell response to SARS-CoV-2 in unexposed individuals.

10 Sep 2021

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

A COVID-19 vaccine, created from a virus-like nanoparticle that displays SARS-CoV-2 spike protein RBDs, effectively protects animal model from infection.

10 Sep 2021

Are bat retroviruses a threat to humans?

Zoonotic viruses that bats transmit are capable of infecting humans and have caused devastating infections throughout the world.

9 Sep 2021

Early impact of COVID-19 vaccines in Stockholm, Sweden

A study shows that the early programmatic effects of vaccinating high-risk individuals can reduce infection and mortality by SARS-CoV-2.

9 Sep 2021

Understanding the changing coronavirus landscape

With the emergence of new SARS-CoV-2 variants such as beta and delta, people are not only getting a refresher course on the Greek alphabet but also experiencing confusion and anxiety about what the variants mean for public health.

9 Sep 2021

SARS News and Research

BU researchers win NIH grant to examine the impact of COVID-19 vaccines on menstruation

The strengths and weaknesses of the spike protein in SARS-CoV-2 variants

Does Delta increase the risk of hospitalization compared with Alpha?

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Multilateral system has failed badly during COVID-19 pandemic, says ISC president-elect

Drugs that mimic effects of cigarette smoke could become a potential tool to fight COVID-19

UGA research offers hope for a viable therapeutic to combat COVID-19

Brown researchers receive $4.9 million to study COVID-19 vaccine effectiveness in older adults

Study identifies FDA-approved drugs that are effective in suppressing SARS-CoV-2 replication

Genomic surveillance of SARS-CoV-2 reveals how the pandemic was caused in Africa

INCB, UNODC and WHO call on governments to facilitate access to controlled medicines in emergencies

Nanoparticles-assisted delivery of antiviral-siRNA for treatment of COVID-19

School children in Switzerland show willingness to mask-wearing

SARS-CoV-2 transmission dynamics in Nordic countries

Breastfeeding women and their babies: the outcomes after mRNA COVID-19 vaccination

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

Are bat retroviruses a threat to humans?

Early impact of COVID-19 vaccines in Stockholm, Sweden

Understanding the changing coronavirus landscape

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News